RxDoctor Payments DataLook up a doctor →

Geover Fernandez, MD

MOHS-Micrographic Surgery · Redondo Beach, CANPI 1639103138

Payments from drug & device makers

$14,079in general payments, 2019–2025

Across 439 payments — averaging $32.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$5K
  • AbbVie$2K
  • Johnson & Johnson$750
  • Amgen$653
  • Novartis$551
  • Sanofi$486
  • plus $4K from 37 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron6$5,312
AbbVie(2 entities)136$2,394
Johnson & Johnson37$750
Amgen31$653
Novartis36$551
Sanofi14$486
Incyte Corporation27$472
E.r. Squibb & Sons, L.L.C.21$414
Sun Pharmaceutical Industries Inc.15$306
UCB, Inc.9$239
Bristol Myers Squibb13$234
Pfizer7$230
LEO Pharma Inc.7$221
Regeneron Healthcare Solutions, Inc.7$162
Smith+Nephew6$150
Galderma Laboratories, L.p.3$148
Biofrontera Inc.6$125
Ortho Dermatologics, A Division Of Bausch Health US, LLC2$107
Octapharma USA, Inc.2$107
Helsinn Therapeutics (U.S.), Inc.7$104
Lilly USA, LLC4$101
Arcutis Biotherapeutics, Inc.6$88
Seagen Inc.5$85
Organogenesis Inc.3$65
Exelixis Inc.3$55
Boehringer Ingelheim2$51
Jazz Pharmaceuticals Inc.3$48
Eisai Inc.2$44
GSK2$43
Dendreon Pharmaceuticals LLC2$42
Genentech USA, Inc.3$38
Tesaro, Inc.1$33
Botanix SB Inc1$28
Stimlabs LLC1$26
Takeda Pharmaceuticals U.S.A., Inc.1$23
Kyowa Kirin, Inc.1$23
Deciphera Pharmaceuticals Inc.1$20
Dermavant Sciences, Inc.1$20
DUSA Pharmaceuticals, Inc.1$20
Morphosys, US Inc.1$18
Puma Biotechnology, Inc.1$17
Daiichi Sankyo Inc.1$17
Merck1$12

How this compares

$14,079 in reported general payments places this provider in the 85th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California →

Medicare billing

Part B allowed, 2024
$2,447,022
Medicare patients
2,314
Services billed
19,400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other mohs-micrographic surgery in Redondo Beach

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →